Form 4: Verrica Pharmaceuticals Executive Sells Shares to Cover Tax Obligations

Joe Bonaccorso, Chief Commercial Officer of Verrica Pharmaceuticals, sold shares to cover statutory tax withholding obligations related to the settlement of restricted stock units.

Summary

• On July 22, 2024, Joe Bonaccorso, the Chief Commercial Officer of Verrica Pharmaceuticals, sold 25,461 shares of common stock at a weighted average price of $7.06.
• On July 23, 2024, Bonaccorso sold an additional 115 shares at $6.98.
• These sales were mandated by Verrica Pharmaceuticals to cover statutory tax withholding obligations related to the settlement of restricted stock units and do not represent discretionary sales by Bonaccorso.
• Following these transactions, Bonaccorso beneficially owns 106,816 shares of Verrica Pharmaceuticals common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the stock sale was to cover tax obligations and not a discretionary sale, suggesting no particular positive or negative view from the executive.

Industry Context

Executive stock sales are a common occurrence and are often related to tax obligations or diversification strategies. The impact on the stock price is usually minimal unless the sales are substantial or indicate a negative outlook by the executive.

Stakeholder Impact

• The stock sale may have a minor impact on shareholders due to the increased supply of shares, but it is unlikely to be significant given the reason for the sale.

Key Dates